Scholar Rock Holding Corp
SRRK
NASDAQ
Biotechnology
$52.52
USD
-0.54 (-1.02%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $6.66B
Volume 496.6K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-408.59M
TTM
-29.4%
YoY
Operating Cash Flow
$-296.83M
TTM
-15.2%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 49.7 | 53.1 | 45.0 | 50.2 | 50.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 112.1 | 103.6 | 91.9 | 102.0 | 108.9 |
Operating Income | -112.1 | -103.6 | -91.9 | -102.0 | -108.9 |
EBITDA | -111.7 | -103.1 | -91.5 | -101.7 | -108.6 |
Other Income / Expense | -0.1 | -0.1 | -0.1 | -4.1 | -0.6 |
Total Other Income / Expense | 2.1 | 1.3 | 0.9 | -3.5 | -1.0 |
Income Before Income Taxes | -110.0 | -102.2 | -91.0 | -105.5 | -109.9 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -110.0 | -102.2 | -91.0 | -105.5 | -109.9 |
Consolidated Net Income / Loss | -110.0 | -102.2 | -91.0 | -105.5 | -109.9 |
Net Income Attributable to Common Shareholders | -110.0 | -102.2 | -91.0 | -105.5 | -109.9 |
Basic EPS | -$0.98 | -$0.90 | -$0.75 | -$0.83 | -$0.84 |
Diluted EPS | -$0.98 | -$0.90 | -$0.75 | -$0.83 | -$0.84 |
Basic Shares Outstanding | 112.7M | 113.7M | 120.5M | 127.3M | 130.6M |
Diluted Shares Outstanding | 112.7M | 113.7M | 120.5M | 127.3M | 130.6M |